Guselkumab is the first and only interleukin-23 inhibitor that offers both subcutaneous and intravenous induction options for ...

Patients with moderate to severe Crohn’s disease who did not achieve clinical response to IV induction with Skyrizi ...

Ulcerative colitis (UC) is a chronic inflammatory disease of the gastrointestinal tract, characterized by inflammation and ...

Crohn's disease is a type of inflammatory bowel disease (IBD) that causes swelling and irritation of the tissues, called ...

A new study suggests AI can predict premature death among people who have inflammatory bowel disease, also known as Crohn's ...

Vitamin B12 is a vital nutrient responsible for red blood cell formation, nerve health, and the creation of DNA. Even though ...

While symptoms of Crohn’s disease, such as abdominal pain, diarrhea, fatigue, and bloating can disrupt daily life, they don’t ...

Erectile dysfunction (ED) affects 30 million men in the U.S. and may be linked to gut health issues like IBS and IBD, which ...

Research shows 47 % of deaths from inflammatory bowel disease are preventable, emphasizing the importance of early ...

Colon cancer, also known as colorectal cancer, is a type of cancer that begins in the large intestine (colon) or the rectum.

The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for adult patients with ...